RESEARCH-USE BIOSIMILAR ANTIBODY
Romosozumab
Monoclonal antibody · IgG2
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis.
TARGETSOST
YMonoclonal antibody
CATALOGSC-BS-211
CATALOG NUMBERSC-BS-211
MOLECULAR WEIGHTApprox. 146.32 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis.
Romosozumab is a recombinant research-use antibody directed against SOST.